⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Rosen Law Firm Urges ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
businesswire.com
SPRY
Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (SPRY) Investors to a Securities Class Action Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)
globenewswire.com
SPRY
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)
globenewswire.com
SPRY
Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. (SPRY) Class Action - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
globenewswire.com
SPRY
SPRY DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
globenewswire.com
SPRY
SPRY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of ARS Pharmaceuticals, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm
globenewswire.com
SPRY
SPRY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of ARS Pharmaceuticals, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm
globenewswire.com
SPRY
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) Investors – Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY